Disentangling Rheumatoid Arthritis Patients' Implicit and Explicit Attitudes toward Methotrexate

被引:12
|
作者
Linn, Annemiek J. [1 ]
Vandeberg, Lisa [1 ]
Wennekers, Annemarie M. [1 ,2 ]
Vervloet, Marcia [3 ]
van Dijk, Liset [3 ]
van den Bemt, Bart J. F. [4 ,5 ,6 ]
机构
[1] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands
[2] Netherlands Inst Social Res, The Hague, Netherlands
[3] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands
[4] Sint Maartensklin, Dept Pharm, Nijmegen, Netherlands
[5] Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands
来源
关键词
medication adherence; implicit attitudes toward medication; rheumatoid arthritis; disease-modifying anti rheumatic drugs (DMARDs); ADHERENCE; BELIEFS; QUESTIONNAIRE; MEDICINES; MODEL;
D O I
10.3389/fphar.2016.00233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medication non-adherence is a major public health problem that has been termed an 'invisible epidemic.' Non-adherence is not only associated with negative clinical consequences but can also result in substantial healthcare costs. Up to now, effective adherence interventions are scarce and a more comprehensive model of adherence determinants is required to target the determinants for not taking the medication as prescribed. Current approaches only included explicit attitudes such as self reported evaluations of medication as determinants, neglecting the role of associative processes that shape implicit attitudes. Implicit processes can predict daily behavior more accurately than explicit attitudes. Our aim is to assess explicit and implicit attitudes toward medication and explore the relation with beliefs, adherence and clinical (laboratory) outcomes in chronically ill patients. Fifty two Rheumatic Arthritis (RA) patients' attitudes toward Methotrexate (MTX) were explicitly (self-reported) and implicitly (Single-Category Implicit Association Test) assessed and related to the Beliefs about Medicine Questionnaire, the Compliance Questionnaire on Rheumatology and laboratory parameters [Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP)]. Results show that explicit attitudes were positive and health-related. Implicit attitudes were, however, negative and sickness-related. Half of the patients displayed explicitly positive but implicitly negative attitudes. Explicit attitudes were positively related to ESR. A positive relationship between implicit attitudes and disease duration was observed. In this study, we have obtained evidence suggesting that the measurement of implicit attitudes and associations provides different information than explicit, self reported attitudes toward medication. Since patients' implicit attitudes deviated from explicit attitudes, we can conclude that the relationship between implicit attitudes and medication adherence is worthwhile to be further explored. With this information we can improve our understanding of the subconscious, automatic processes underlying adherence and we can develop interventions that target these implicit attitudes.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Controlled and implicit processes in evaluative conditioning on implicit and explicit attitudes toward alcohol and intentions to drink
    Zerhouni, Oulmann
    Begue, Laurent
    Comiran, Francisco
    Wiers, Reinout W.
    ADDICTIVE BEHAVIORS, 2018, 76 : 335 - 342
  • [42] METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SINNETT, MJ
    GROFF, GD
    RADDATZ, DA
    FRANCK, WA
    BERTINO, JS
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (06) : 745 - 748
  • [43] METHOTREXATE IN OLDER PATIENTS WITH RHEUMATOID-ARTHRITIS
    POOLE, P
    YEOMAN, S
    CAUGHEY, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (12): : 860 - 860
  • [44] Optimalization of the therapy with methotrexate by patients with rheumatoid arthritis
    Swierkol, J
    Hojenska, AW
    Wiland, P
    Orzechowska-Juzwenko, K
    Hurkacz, M
    Szechinski, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 405 - 406
  • [45] METHOTREXATE DOSE AND OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, C. -B.
    Sung, Y. -K.
    Cho, S. -K.
    Yoo, D. -H.
    Lee, S. -S.
    Lee, J.
    Kim, J.
    Lee, H. -S.
    Kim, T. -H.
    Yoon, B. Y.
    Yoo, W. -H.
    Choe, J. -Y.
    Lee, S. -H.
    Shim, S. -C.
    Chung, W. -T.
    Hong, S. -J.
    Lee, C. K.
    Koh, E.
    Jun, J. -B.
    Bang, S. -Y.
    Kim, S. -K.
    Cha, H. -S.
    Shim, J.
    Bae, S. -C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 836 - 836
  • [46] Predicting methotrexate resistance in rheumatoid arthritis patients
    Yu, Mary Beth
    Firek, Anthony
    Langridge, William H. R.
    INFLAMMOPHARMACOLOGY, 2018, 26 (03) : 699 - 708
  • [47] Methotrexate for rheumatoid arthritis patients who are on hemodialysis
    Al-Hasani, Hasanein
    Roussou, Euthalia
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (12) : 1545 - 1547
  • [48] Determinants of methotrexate adherence in rheumatoid arthritis patients
    De Cuyper, Ellen
    De Gucht, Veronique
    Maes, Stan
    Van Camp, Yoleen
    De Clerck, Luc S.
    CLINICAL RHEUMATOLOGY, 2016, 35 (05) : 1335 - 1339
  • [49] METHOTREXATE ADHERENCE IN MOROCCAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Toufik, Hamza
    Djossou, Julien
    Ghassem, Mohamed A.
    Ouardi, Najlae E. L.
    Majjad, Abderrahim
    Maghraoui, Abdellah E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1688 - 1688
  • [50] Pharmacokinetics of Oral Methotrexate in Patients With Rheumatoid Arthritis
    Dalrymple, Judith M.
    Stamp, Lisa K.
    O'Donnell, John L.
    Chapman, Peter T.
    Zhang, Mei
    Barclay, Murray L.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3299 - 3308